Literature DB >> 27498412

Micro- and macro-metastasis in the axillary lymph node: A review.

Kalnisha Naidoo1, Sarah E Pinder2.   

Abstract

Pathologists typically examine the sentinel lymph nodes excised from patients with invasive breast cancer more thoroughly than they have historically those from axillary lymph node clearance specimens. This, it is thought, increases the chances of detecting small metastatic foci (i.e. macrometastases (>2 mm), micrometastases (0.2-2 mm), or isolated tumour cell clusters (<0.2 mm or <200 cancer cells in one section)). However, the clinical significance of these small metastatic deposits remains unclear. Although an increasing nodal burden is known to proportionally decrease patient survival, the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial has, at the least, raised questions as to how best to manage nodal metastasis in early invasive breast cancer. These issues, and a brief overview of the biology of metastatic spread are presented in this review.
Copyright © 2016 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axilla; Macrometastasis; Micrometastasis; Sentinel lymph node

Mesh:

Year:  2016        PMID: 27498412     DOI: 10.1016/j.surge.2016.07.002

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  7 in total

1.  Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.

Authors:  Fabian Riedel; Jörg Heil; Manuel Feißt; Mahdi Rezai; Mareike Moderow; Christof Sohn; Florian Schütz; Michael Golatta; André Hennigs
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

2.  Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling.

Authors:  Shixin Xia; Xiulan Zhang; Caihong Li; Honglian Guan
Journal:  Saudi Pharm J       Date:  2017-05-10       Impact factor: 4.330

3.  Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment.

Authors:  Julia Stevenson; Rachel Barrow-McGee; Lu Yu; Angela Paul; David Mansfield; Julie Owen; Natalie Woodman; Rachael Natrajan; Syed Haider; Cheryl Gillett; Andrew Tutt; Sarah E Pinder; Jyoti Choudary; Kalnisha Naidoo
Journal:  NPJ Breast Cancer       Date:  2021-03-05

4.  Presence of Dendritic Cell Subsets in Sentinel Nodes of Breast Cancer Patients Is Related to Nodal Burden.

Authors:  Joanna Szpor; Joanna Streb; Anna Glajcar; Piotr Sadowski; Anna Streb-Smoleń; Robert Jach; Diana Hodorowicz-Zaniewska
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

5.  Thematic trends and knowledge structure map of sentinel lymph node biopsy for breast cancer: a bibliometric analysis from 2010 to 2019.

Authors:  Yujie Huo; Ting Fan; Si Chen; Qiannan Liu; Yue Fang; Fan Yao
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

6.  Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.

Authors:  Dalia Rukanskienė; Vincentas Veikutis; Eglė Jonaitienė; Milda Basevičiūtė; Domantas Kunigiškis; Renata Paukštaitienė; Daiva Čepulienė; Lina Poškienė; Algirdas Boguševičius
Journal:  Medicina (Kaunas)       Date:  2020-03-13       Impact factor: 2.430

7.  Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.

Authors:  Rachel Barrow-McGee; Julia Procter; Julie Owen; Natalie Woodman; Cristina Lombardelli; Ashutosh Kothari; Tibor Kovacs; Michael Douek; Simi George; Peter A Barry; Kelvin Ramsey; Amy Gibson; Richard Buus; Erle Holgersen; Rachael Natrajan; Syed Haider; Michael J Shattock; Cheryl Gillett; Andrew Nj Tutt; Sarah E Pinder; Kalnisha Naidoo
Journal:  J Pathol       Date:  2019-12-22       Impact factor: 7.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.